British drug regulator recalls India's Wockhardt medicines
British drug regulator MHRA issued a precuationary recall to 16 medicines manufactured by Indian pharmaceutical company Wockhardt. The regulator had identified deficiencies in manufacturing procedures at the company's Waluj site in India.
July 12, 2013 / 09:32 IST
Britain's drugs regulator MHRA on Thursday said it would withdraw some medicines made by India's Wockhardt Ltd after it identified deficiencies in manufacturing procedures at Wockhardt's Waluj site in India.
The 16 medicines affected by the precautionary recall include those used for the treatment of infections, high blood pressure, diabetes, epilepsy, depression, schizophrenia, Parkinson's disease, dementia in Alzheimer's patients and thyroid conditions.Also read: UK regulator issues import alert on Wockhardt's Waluj plantThe MHRA said patients did not need to return their medicines because there was no evidence that the medicines affected by the precautionary recall in the UK were defective."However, the MHRA has to act in the interests of public health as poor manufacturing standards cannot be allowed to continue," it said. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
